Xiao‐Kang Jin

1.1k total citations · 1 hit paper
32 papers, 847 citations indexed

About

Xiao‐Kang Jin is a scholar working on Biomedical Engineering, Immunology and Molecular Biology. According to data from OpenAlex, Xiao‐Kang Jin has authored 32 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Biomedical Engineering, 12 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Xiao‐Kang Jin's work include Nanoplatforms for cancer theranostics (22 papers), Nanoparticle-Based Drug Delivery (7 papers) and Immune cells in cancer (7 papers). Xiao‐Kang Jin is often cited by papers focused on Nanoplatforms for cancer theranostics (22 papers), Nanoparticle-Based Drug Delivery (7 papers) and Immune cells in cancer (7 papers). Xiao‐Kang Jin collaborates with scholars based in China and United States. Xiao‐Kang Jin's co-authors include Xian‐Zheng Zhang, Jun‐Long Liang, Qian‐Xiao Huang, Shi‐Man Zhang, Bing Wang, Chuan‐Jun Liu, Wei‐Hai Chen, Mei‐Ting Niu, Chengyuan Dong and Qi‐Wen Chen and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Xiao‐Kang Jin

31 papers receiving 834 citations

Hit Papers

Metal-organic framework nanoagent induces cuproptosis for... 2023 2026 2024 2025 2023 40 80 120

Peers

Xiao‐Kang Jin
Xiao‐Kang Jin
Citations per year, relative to Xiao‐Kang Jin Xiao‐Kang Jin (= 1×) peers Huihai Zhong

Countries citing papers authored by Xiao‐Kang Jin

Since Specialization
Citations

This map shows the geographic impact of Xiao‐Kang Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Kang Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Kang Jin more than expected).

Fields of papers citing papers by Xiao‐Kang Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Kang Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Kang Jin. The network helps show where Xiao‐Kang Jin may publish in the future.

Co-authorship network of co-authors of Xiao‐Kang Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Kang Jin. A scholar is included among the top collaborators of Xiao‐Kang Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Kang Jin. Xiao‐Kang Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Xiao‐Kang, et al.. (2025). An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer. Nature Nanotechnology. 20(7). 935–946. 10 indexed citations
2.
Liang, Jun‐Long, Qian‐Xiao Huang, Qi‐Wen Chen, et al.. (2025). Perturbing Organelle‐Level K+/Ca2+ Homeostasis by Nanotherapeutics for Enhancing Ion‐Mediated Cancer Immunotherapy. Advanced Materials. 37(12). e2416574–e2416574. 7 indexed citations
3.
Liang, Jun‐Long, Xiao‐Kang Jin, Qian‐Xiao Huang, et al.. (2024). Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy. Materials Today. 78. 251–296. 14 indexed citations
4.
Liu, Feng, Jiale Li, Ziying Zhang, et al.. (2024). Antimonene and bacterial outer membrane vesicle modification nanoplatform enhanced photothermal immunotherapy. Surfaces and Interfaces. 56. 105556–105556. 4 indexed citations
5.
Campos, Miguel, Xiao‐Kang Jin, Chenlu Zhang, et al.. (2024). Exploiting the DCAF16–SPIN4 interaction to identify DCAF16 ligands for PROTAC development. RSC Medicinal Chemistry. 16(2). 892–906. 2 indexed citations
6.
Zhang, Chenlu, et al.. (2024). A platform for mapping reactive cysteines within the immunopeptidome. Nature Communications. 15(1). 9698–9698.
7.
Kuang, Jing, Ting Pan, Qian‐Xiao Huang, et al.. (2024). Cationic Magnetic Nanoparticles Activate Natural Killer Cells for the Treatment of Glioblastoma. ACS Nano. 19(1). 649–661. 7 indexed citations
8.
Ji, Ping, Xiao‐Kang Jin, Shi‐Man Zhang, et al.. (2024). Metabolic Regulation-Mediated Reversion of the Tumor Immunosuppressive Microenvironment for Potentiating Cooperative Metabolic Therapy and Immunotherapy. Nano Letters. 24(15). 4691–4701. 6 indexed citations
9.
Yan, Xiao, Cheng Zhang, Xiao‐Kang Jin, et al.. (2024). Lactate/Cysteine Dual-Consuming Probiotic–Nanomedicine Biohybrid System for Enhanced Cancer Chemo-Immunotherapy. Nano Letters. 24(50). 16132–16142. 6 indexed citations
10.
Liang, Jun‐Long, Xiao‐Kang Jin, Shi‐Man Zhang, et al.. (2023). Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy. Science Bulletin. 68(6). 622–636. 96 indexed citations
11.
Liu, Feng, et al.. (2023). Nanoarchitectonics of versatile platform based on graphene oxide for precise and enhanced synergistic cancer photothermal-photodynamic/chemotherapy. Journal of Molecular Structure. 1294. 136499–136499. 4 indexed citations
12.
Liu, Xinhua, Jia‐Xin An, Jun‐Long Liang, et al.. (2023). Dendritic Cell-Based In Situ Nanovaccine for Reprogramming Lipid Metabolism to Boost Tumor Immunotherapy. ACS Nano. 17(24). 24947–24960. 24 indexed citations
13.
Huang, Qian‐Xiao, Jun‐Long Liang, Qi‐Wen Chen, et al.. (2023). Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma. Nano Today. 51. 101911–101911. 123 indexed citations breakdown →
14.
Liang, Jun‐Long, Xiao‐Kang Jin, Guo‐Feng Luo, et al.. (2023). Immunostimulant Hydrogel-Guided Tumor Microenvironment Reprogramming to Efficiently Potentiate Macrophage-Mediated Cellular Phagocytosis for Systemic Cancer Immunotherapy. ACS Nano. 17(17). 17217–17232. 47 indexed citations
15.
Zhang, Shi‐Man, Xiao‐Kang Jin, Guo‐Feng Luo, et al.. (2023). An Engineered Bacterium-Based Lactate Bioconsumer for Regulating Immunosuppressive Tumor Microenvironment to Potentiate Antitumor Immunity. ACS Materials Letters. 5(10). 2785–2798. 14 indexed citations
16.
Jin, Xiao‐Kang, Jun‐Long Liang, Shi‐Man Zhang, et al.. (2023). Engineering metal-based hydrogel-mediated tertiary lymphoid structure formation via activation of the STING pathway for enhanced immunotherapy. Materials Horizons. 10(10). 4365–4379. 40 indexed citations
17.
Liang, Jun‐Long, Mei‐Ting Niu, Guo‐Feng Luo, et al.. (2022). Tailor-made biotuner against colorectal tumor microenvironment to transfer harms into treasures for synergistic oncotherapy. Nano Today. 47. 101662–101662. 12 indexed citations
18.
Jin, Xiao‐Kang, Yang Huang, Zhengwei Mao, & Bing Wang. (2021). Cathepsin B-responsive multifunctional peptide conjugated gold nanorods for mitochondrial targeting and precise photothermal cancer therapy. Journal of Colloid and Interface Science. 601. 714–726. 38 indexed citations
19.
Lin, Wenxin, et al.. (2021). A theranostic Mn-based metal-organic framework for T1-weighted magnetic resonance property and chemodynamic therapy. Polyhedron. 205. 115278–115278. 12 indexed citations
20.
Liang, Jun‐Long, Xiao‐Kang Jin, Biling Chen, et al.. (2020). Doxorubicin-loaded pH-responsive nanoparticles coated with chlorin e6 for drug delivery and synergetic chemo-photodynamic therapy. Nanotechnology. 31(19). 195103–195103. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026